Roche declares early win for oral GLP-1 drug it bought from Carmot
Roche’s $2.7 billion acquisition of Carmot Therapeutics delivered another success this week.
The Swiss pharma said Wednesday morning that its oral GLP …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
